For Immediate Release:
Cannabis / Testing / Laboratories
AZDHS ISSUES VOLUNTARY CANNABIS PRODUCT RECALL IN LAB TESTING DISCREPANCY
“OnPoint Laboratories takes full responsibility, and reiterated today that all of the products, dispensary companies and brands associated with this recall have always followed rigorous state testing requirements and continuously provide clean products for consumers,” stated an OnPoint Laboratories spokesperson.
SNOWFLAKE, Ariz., (June 24, 2021) — OnPoint Laboratories (the “Company”) was recently alerted by the Arizona Department of Health Services (AZDHS) of a voluntary cannabis recall related to the Company’s testing of possible product contamination for Salmonella and Aspergillus. To date, no illnesses have been reported based on the products involved with the voluntary recall.
OnPoint Labs fully supports AZDHS in their efforts to ensure clean products for consumers.
“Their bi-annual audits and reports are essential and the AZDHS system is working. While this recall was issued out of an abundance of caution, it exemplifies the excellent teamwork of the agency, the labs and the cannabis companies that serve Arizona consumers,” said an OnPoint Laboratories spokesperson.
Earlier this year, OnPoint Laboratories issued clean certificate of analysis (COA) statements for a limited number of affected samples and believed the products to be safe and the results to be accurate. In a subsequent audit by AZDHS, the agency disputed these results and stated it found potential for contamination. Although OnPoint Labs initially believed the test results to be negative, the company feels an abundance of caution is the right approach.
The products, dispensary companies, brands, and OnPoint Laboratories were unaware of any discrepancies until they were notified by the state agency. OnPoint Laboratories takes full responsibility, and reiterated today that all of the products, dispensary companies and brands associated with this recall have always followed rigorous state testing requirements and continuously provide clean products for consumers.
A Company spokesperson indicated the voluntary recall is not the result of any wrongdoing by the products, dispensaries, or brands, but rather an audit-based testing discrepancy between OnPoint Laboratories and AZDHS.
OnPoint Laboratories and its customers have consistently followed the guidelines and recommendations of AZDHS. As policies and procedures evolve, the Company will maintain the highest level of compliance to these standards
OnPoint Laboratories continues to focus on distinguished service and providing test results that keep patients and adult-use customers safe.
OnPoint Laboratories will issue further statements as the situation develops.
Ashley Oakes Scott